HomeBVX • LON
add
Bivictrix Therapeutics PLC
Previous close
GBX 13.00
Year range
GBX 9.00 - GBX 15.42
Market cap
10.73M GBP
Avg Volume
2.60K
P/E ratio
-
Dividend yield
-
Primary exchange
LON
Market news
Financials
Income Statement
Revenue
Net income
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 817.50K | 14.74% |
Net income | -687.00K | -18.76% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -802.50K | -14.64% |
Effective tax rate | 14.82% | — |
Balance Sheet
Total assets
Total liabilities
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.28M | -0.24% |
Total assets | 4.30M | -5.31% |
Total liabilities | 758.00K | 30.92% |
Total equity | 3.54M | — |
Shares outstanding | 82.53M | — |
Price to book | 3.25 | — |
Return on assets | -47.58% | — |
Return on capital | -53.80% | — |
Cash Flow
Net change in cash
(GBP) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -687.00K | -18.76% |
Cash from operations | -368.50K | 31.51% |
Cash from investing | 88.50K | 195.68% |
Cash from financing | 967.50K | — |
Net change in cash | 687.50K | 209.04% |
Free cash flow | -374.94K | 16.18% |
About
Founded
2016
Website
Employees
17